Heranba Industries experienced a 4.83% rise in its share price, reaching ₹201.95, following the introduction of its new crop nutrition products, Fentaamine and MycoHil. Fentaamine is a bio stimulant that enhances plant metabolism and stress tolerance, while MycoHil is a biofertilizer that improves nutrient absorption and promotes sustainable farming. Developed in collaboration with a leading American multinational, these products align with Heranba's Vision 2026 strategy, which targets a total turnover of ₹2,500 crore this fiscal year. The company also plans to expand its footprint to over 80 countries, including a new subsidiary in Dubai to strengthen its presence in the Middle East and Africa. R. K. Shetty, managing director of Heranba, emphasized the strong growth potential in the crop nutrition segment, which is seeing a CAGR of over 15% globally. Despite reporting a consolidated net loss of ₹23.25 crore in Q3 FY26, down from a net loss of ₹10.19 crore in Q3 FY25, the company remains focused on enhancing crop productivity and supporting global food security initiatives.